Current challenges in HER2-positive breast cancer-Reference-Cited by-同舟云学术

Current challenges in HER2-positive breast cancer

Published:2016-02 Issue: Volume:98 Page:211-221
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Puglisi Fabio,Fontanella Caterina,Amoroso Vito,Bianchi Giulia Valeria,Bisagni Giancarlo,Falci Cristina,Fontana Andrea,Generali Daniele,Gianni Lorenzo,Grassadonia Antonio,Moscetti Luca,Portarena Ilaria,Rossi Emanuela,Marchetti Paolo

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference114 articles.

1. Prognosis and outcome of small (<=1cm), node-negative breast cancer on the basis of hormonal and HER-2 status;Amar;Oncologist,2010

2. Anon., 2015a. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000278/WC500126896.pdf (accessed 22.03.15).

3. Anon., 2015b. http://www.roche.com/media/store/releases/med-cor-2013-03-05.htm (accessed 22.03.15).

4. Anon., 2015c. https://clinicaltrials.gov/ct2/show/NCT00593697 (accessed 22.03.15).

5. Anon., 2015d. http://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/maerz2014/en/2014_englisch_all.pdf (accessed 22.03.15).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor activities against breast cancers by an afucosylated anti‐HER2 monoclonal antibody H₂Mab‐77‐mG_2a‐f;Cancer Science;2023-11-09

2. HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept;Cancers;2023-05-09

3. Data on 2D culture characterisation of potential markers in human HER2-positive breast cancer cell lines;Data in Brief;2023-02

4. Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor;Molecular Pharmaceutics;2023-01-20

5. Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor;Frontiers in Oncology;2022-12-21